scispace - formally typeset
Open AccessJournal ArticleDOI

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Reads0
Chats0
TLDR
In this article, the authors evaluated the neutralization potency of 99 individuals that received one or two doses of either BNT162b2 or mRNA-1273 vaccines against pseudoviruses representing 10 globally circulating strains of SARS-CoV-2.
About
This article is published in Cell.The article was published on 2021-04-29 and is currently open access. It has received 1109 citations till now. The article focuses on the topics: Vaccination & Humoral immunity.

read more

Citations
More filters
Journal ArticleDOI

Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.

TL;DR: In this paper, the authors explored the effectiveness of MVC-COV1901 against the VoCs and showed that immunization with MVC was effective against VoCs in rats and humans.
Journal ArticleDOI

Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage.

TL;DR: In this paper, the authors reported the recent spread of a new SARS-CoV-2 spike 501Y variant, which is the first of Nextstrain clade 19B.
Journal ArticleDOI

Thermodynamically coupled biosensors for detecting neutralizing antibodies against SARS-CoV-2 variants

TL;DR: In this paper , a protein biosensor that uses thermodynamic coupling for sensitive and rapid detection of neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in serum was designed.
Journal ArticleDOI

Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination

TL;DR: In this paper , the authors calculate the seroconversion rate and IgG antibody dynamic range of the CoronaVac vaccine in healthcare workers (HCWs) after immunization, and show that the vaccine has a high serocversion rate when evaluated in an HCW population.
References
More filters
Journal ArticleDOI

SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

TL;DR: Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity.
Related Papers (5)